[visionlist] Vaegan seminar: A/Prof Mohit Shivdasani (UNSW Sydney)

Juno Kim juno.kim at unsw.edu.au
Thu Feb 17 14:39:41 -05 2022


Dear friends,



Apologies for the late notice; the Vaegan seminar is today. I will aim to record this for anyone who misses the event.


Our first Vaegan seminar for 2022 will be held at 1pm Friday 18
February 2022 (AEDT) and will be presented by A/Prof Mohit Shivdasani (UNSW Sydney). A/Prof Shivdasani's talk is entitled: "Emerging engineering technologies for sight restoration in central visual pathway dystrophies”



This event will be held remotely via Zoom.



Meeting information and connection details are provided below.



Looking forward to seeing you there. NO RSVP REQUIRED (the meeting password is embedded in the link).



Best regards,



Juno



Title: Emerging engineering technologies for sight restoration in central visual pathway dystrophies

Speaker: A/Prof Mohit Shivdasani (UNSW Sydney)

Time: 1-2pm Friday 18 February 2022 (AEDT)

Join from PC, Mac, Linux, iOS or Android:
https://unsw.zoom.us/j/83023210928?pwd=c2tBL2lsdFJMQldaTjNiT09DRVhTQT09

Abstract: Many dystrophies causing blindness either directly affect the retina or areas further up the central visual pathway. The last decade has seen an explosion of engineering technologies (some very expensive ones and some not so much!) that promise to be the next “game changer” in restoring sight for patients affected by these dystrophies. This talk aimed at a broad audience, will give an overview of some of the technologies that have made more headlines in the last few years, including their premise, the science behind their “real” benefits, some of the hype, and yet to be resolved pitfalls and challenges.

Bio: A/Prof Mohit Shivdasani is an Associate Professor in Bionics and Neuromodulation in the Graduate School of Biomedical Engineering at UNSW. A/Prof Shivdasani began his bionics career in the field of artificial hearing, developing a brain stimulation device for his PhD (awarded 2009), which morphed into a postdoctoral stint at the Bionics Institute in Melbourne over 8 years that developed Australia’s first bionic eye for artificial vision, going from concept to first-in-human trials in 3 years. Since 2018, A/Prof Shivdasani has been at UNSW in a research and teaching capacity and has been continuing to dabble in sight restoration research as well as developing various other bionic technologies, the newest of which is a device to treat neuroinflammation of the gut for inflammatory bowel disease.

Juno Kim | PhD (Psychology) | Associate Professor
School of Optometry and Vision Science
UNSW MEDICINE AND HEALTH
UNSW SYDNEY NSW 2052 AUSTRALIA
E: juno.kim at unsw.edu.au<mailto:juno.kim at unsw.edu.au>  | T: +61 2 9065 1218<mailto:juno.kim at unsw.edu.au>
Skype: junokim39
CRICOS Provider Code 00098G

School of Optometry and Vision Science Mission Statement:
‘Advancing vision and eye health in society through world-class, innovative, multi-disciplinary education and research'

________________________________
From: Juno Kim
Sent: Thursday, February 17, 2022 10:44 PM
To: visionlist at visionscience.com <visionlist at visionscience.com>
Subject: Vaegan seminar: A/Prof Mohit Shivdasani (UNSW Sydney)


Dear friends,



Our first Vaegan seminar for 2022 will be held at 1pm Friday 18
November 2022 (AEDT) and will be presented by A/Prof Mohit Shivdasani (UNSW Sydney). A/Prof Shivdasani's talk is entitled: "Emerging engineering technologies for sight restoration in central visual pathway dystrophies”



This event will be held remotely via Zoom.



Meeting information and connection details are provided below.



Looking forward to seeing you there. NO RSVP REQUIRED (the meeting password is embedded in the link).



Best regards,



Juno



Title: Emerging engineering technologies for sight restoration in central visual pathway dystrophies

Speaker: A/Prof Mohit Shivdasani (UNSW Sydney)

Time: 1-2pm Friday 18 February 2022 (AEDT)

Join from PC, Mac, Linux, iOS or Android:
https://unsw.zoom.us/j/83023210928?pwd=c2tBL2lsdFJMQldaTjNiT09DRVhTQT09

Abstract: Many dystrophies causing blindness either directly affect the retina or areas further up the central visual pathway. The last decade has seen an explosion of engineering technologies (some very expensive ones and some not so much!) that promise to be the next “game changer” in restoring sight for patients affected by these dystrophies. This talk aimed at a broad audience, will give an overview of some of the technologies that have made more headlines in the last few years, including their premise, the science behind their “real” benefits, some of the hype, and yet to be resolved pitfalls and challenges.

Bio: A/Prof Mohit Shivdasani is an Associate Professor in Bionics and Neuromodulation in the Graduate School of Biomedical Engineering at UNSW. A/Prof Shivdasani began his bionics career in the field of artificial hearing, developing a brain stimulation device for his PhD (awarded 2009), which morphed into a postdoctoral stint at the Bionics Institute in Melbourne over 8 years that developed Australia’s first bionic eye for artificial vision, going from concept to first-in-human trials in 3 years. Since 2018, A/Prof Shivdasani has been at UNSW in a research and teaching capacity and has been continuing to dabble in sight restoration research as well as developing various other bionic technologies, the newest of which is a device to treat neuroinflammation of the gut for inflammatory bowel disease.

Juno Kim | PhD (Psychology) | Associate Professor
School of Optometry and Vision Science
UNSW MEDICINE AND HEALTH
UNSW SYDNEY NSW 2052 AUSTRALIA
E: juno.kim at unsw.edu.au<mailto:juno.kim at unsw.edu.au>  | T: +61 2 9065 1218<mailto:juno.kim at unsw.edu.au>
Skype: junokim39
CRICOS Provider Code 00098G

School of Optometry and Vision Science Mission Statement:
‘Advancing vision and eye health in society through world-class, innovative, multi-disciplinary education and research'

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://visionscience.com/pipermail/visionlist_visionscience.com/attachments/20220217/8f18dc79/attachment-0001.html>


More information about the visionlist mailing list